Clinical Nutrition Market Is Expected To Grow At 4.13% CAGR

The North American region led the clinical nutrition market in 2021.

As per our report, the global clinical nutrition market size was valued at USD 14.58 billion in 2022 to USD 17.85 Billion by 2027, with a CAGR of 4.13% during the forecast period.

The COVID-19 pandemic is likely to impact the clinical nutrition products market significantly, as the need for nutritional management continues to rise, particularly among youngsters and the elderly. Consumers seek various immunity-boosting alternatives to avoid being infected by the novel coronavirus, and demand for therapeutic nutrition products is rising because of the ongoing COVID-19 problem. In addition, older adults and patients are at risk of malnutrition due to the pandemic's beginning. The illness also causes a loss of appetite and other symptoms such as anosmia dysgeusia or diarrhea, which increase the risk of malnutrition. In addition, COVID-19 infection produced acute starvation, resulting in a loss of muscle mass and weakened immune systems.

The COVID-19 pandemic has become an unexpected public health threat with significant implications for the clinical nutrition industry. Millions of people have been affected by the coronavirus outbreak, which has resulted in a high mortality toll. In addition, the ongoing COVID-19 pandemic and statewide lockdowns implemented in many nations have impacted the therapeutic nutrition sector.

The rise in the prevalence of metabolic disorders and rising cases of metabolic cases are driving the growth of the global clinical nutrition market. However, other factors such as the increasing number of pre-mature births and unhealthy dietary habits lead to malnutrition and the growing geriatric population boost market growth. In addition, the high healthcare expenditure in emerging countries such as the United States, UK, and China provides lucrative growth opportunities for the new market players through investments.

On the other hand, clinical nutrition focuses on diagnosing, treating, and preventing nutritional and metabolic diseases linked with chronic or acute disorders caused by nutrient and energy deficiency. Most importantly, nutritional aid is provided for various reasons, including minimizing the effects of hunger and enhancing disease treatment response. When nutrient absorption or food intake is limited for an extended period, clinical nutrition support is essential to avoid famine and other serious repercussions. The growing geriatric population is significantly contributing to the clinical nutrition market due to the rising number of senior people and the development of therapeutic nutrition products tailored to the needs of the aged. According to the Global Coalition on Aging study, November 2020, the prevalence of malnutrition in hospitalized patients was around 31%. According to the Global Surgery Foundation, nearly 30% of worldwide diseases can be treated with surgery and require the direct care of a surgeon. According to the Global Coalition on Aging study, November 2020, the prevalence of malnutrition in hospitalized patients was around 31%.

Furthermore, the Global Surgery Foundation estimates that almost 30% of all disorders in the world can be treated with surgery and require the direct attention of a surgeon. Therefore, clinical nutrition is important during surgeries since it helps to minimize any adverse effects on patients while also allowing surgeons to work in a controlled environment.

However, a lack of information, particularly in emerging nations, and strict government rules are only a few barriers that may limit the use of alternative nutrition methods. In addition, the expansion of the clinical nutrition industry may be hampered in the world's least developed countries, which have substantially lower living standards, due to a refusal of rationalized methods of nutrition consumption and a lack of adoption of modern approaches.

Avail sample market brochure of the report to evaluate its usefulness; get a copy @ https://www.marketdataforecast.com/market-reports/clinical-nutrition-market/request-sample

KEY MARKET INSIGHTS:

Based on the route of administration, the oral clinical nutrition market dominated by route of administration in 2020 and is expected to continue to do so during the forecast period, owing to an increase in malnourished patients with malignancy, chronic disease, and anorexia, as well as an increase in the incidences of chronic diseases such as cancer, gastrointestinal disorders, and metabolic disorders. Furthermore, the enteral segment is expected to increase at the quickest rate during the projection period, with a CAGR of 7.30 percent.
Based on the therapeutic areas, due to recent growth in the number of diabetic patients, the diabetic segment is leading the clinical nutrition market in terms of therapeutic areas. In addition, the cancer market is expanding at a rapid pace.
Based on the ingredients type, the vitamins category contributes significantly to the clinical nutrition market and is predicted to rise during the forecast period based on ingredient type.
Geographically, North America dominates the global market and is expected to continue to do so due to high R&D spending, significant players and their product availability, and the region's advanced healthcare infrastructure. As a result, hospitals and clinics are better equipped to deliver healthcare to patients who require disease-specific nutrition. Such advances are predicted to boost clinical nutrition management adoption among patients, boosting industry statistics shortly.
After North America, Europe is the second-largest market, and it is fast expanding due to high malnutrition rates and an aging population prone to different diseases. The revenue contribution to the regional expansion of clinical trials is split between Germany and the United Kingdom.
However, Asia-Pacific is predicted to grow fastest over the forecast period as Asian governments such as China, Japan, and India invest in healthcare infrastructure development. Emerging countries such as China, Japan, and India significantly contribute to the APAC regional market growth. However, China accounted for the highest share of the Asia Pacific regional market growth. Similarly, the Indian clinical nutrition market is projected to witness a promising share in the coming period due to supportive government policies, investments by private organizations, and protein-energy malnutrition. As a result, the country has shown progress towards achieving the target for obesity. Also, it is estimated to affect 9.0% of adult women and 10.2% of adult men.
Abbott Laboratories (Abbott Nutrition), B Braun Melsungen AG, Baxter International Inc., Fresenius Kabi, Mead Johnson (Reckitt Benckiser), Nestle Health Science, Perrigo, Pfizer, Inc., Danone, and Hero Nutritionals Inc. are some of the prominent companies in the clinical nutrition market. These industry leaders employ new technology to meet consumers' increasing demand for highly nutritional products.